Free Shipping on purchases over €100

Foreo Iris™ Pro-Strength Eyelash Serum

FOREO Eyelashes Eyelash Serum is a powerful, concentrated, natural treatment designed to protect, strengthen and volumise lashes. It is part of the eye-focused IRIS™ collection and contains 97% ingredients of natural origin.

SKU: FO7350120790910
-26%
Up to 50% discount.
47.80
€64.90

Pharmaceutical Care

Safe medication sales

Secure shipping

INFO AND TECHNICAL SPECIFICATIONS

Powerful, concentrated and natural serum to protect, strengthen and provide spectacular volume.
False lashes are like false promises: they're short-lived. That's why we've worked hard to fuse the best of nature to give you a voluminous, dramatic look every day from the inside out. The advanced formula of this lash serum gathers premium ingredients from nature, and precisely combines them to give you visible, sustainable results that enhance what you already have.

Part of the eye-focused IRIS™ collection, FOREO Eyelashes eyelash serum formula contains 97% naturally derived ingredients that nourish, protect and strengthen to take your beauty routine to the next level. Phytokeratin and L-Arginine strengthen and protect lashes, while Gingko Biloba extract enhances growth and hydration. This powerful, concentrated all-in-one treatment is ideal for dramatically fuller, denser lashes without the uncomfortable feeling of heaviness and with fast absorption.

This surprisingly light, natural, safe and gentle serum has been developed with only the purest extracts and is suitable for all skin types. Dermatologically tested, vegan, cruelty-free and fragrance-free, it has been formulated without FOREO's extensive list of ingredients to avoid. Who says you can't just blink to get what you want?

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.